Axogen, Inc. Inventory Write-down
Axogen, Inc. (AXGN) reported Inventory Write-down of $4.53 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-02-24
- Axogen, Inc. inventory write-down for the quarter ending 2024-06-30 was $1.96M, a 315.92% increase year-over-year.
- Axogen, Inc. inventory write-down for the quarter ending 2024-03-31 was $367.00K, a 36.83% decline year-over-year.
- Axogen, Inc. inventory write-down for the quarter ending 2023-12-31 was $98.00K, a 74.74% decline year-over-year.
- Axogen, Inc. inventory write-down for the quarter ending 2023-09-30 was $789.00K, a 74.56% increase year-over-year.
- Axogen, Inc. inventory write-down for fiscal 2025 was $4.53M, a 35.13% decline from fiscal 2024.
- Axogen, Inc. inventory write-down for fiscal 2024 was $6.99M, a 260.44% increase from fiscal 2023.
- Axogen, Inc. inventory write-down for fiscal 2023 was $1.94M, a 9.61% increase from fiscal 2022.
- Axogen, Inc. inventory write-down for fiscal 2022 was $1.77M, a 46.62% decline from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 6 month as first filed | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4.53M 10-K · filed 2026-02-24 | |||||
| 2024-12-31 | $6.99M 10-K · filed 2026-02-24 | |||||
| 2024-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.33M 10-Q · filed 2024-08-08 | $2.42M derived: sum of 3 quarters · filed 2026-02-24 | $3.21M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $367.00K 10-Q · filed 2024-05-02 | $465.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.25M derived: sum of 3 quarters · filed 2026-02-24 | $1.73M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $887.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.36M derived: sum of 3 quarters · filed 2026-02-24 | $1.94M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $789.00K 10-Q · filed 2023-11-07 | $1.26M derived: sum of 2 quarters · filed 2023-11-07 | $1.84M 10-Q · filed 2023-11-07 | $2.23M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $471.00K 10-Q · filed 2023-08-08 | $1.05M 10-Q · filed 2024-08-08 | $1.44M derived: sum of 3 quarters · filed 2025-02-26 | $1.89M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $581.00K 10-Q · filed 2024-05-02 | $969.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.42M derived: sum of 3 quarters · filed 2025-02-26 | $1.89M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $840.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.31M derived: sum of 3 quarters · filed 2025-02-26 | $1.77M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $452.00K 10-Q · filed 2023-11-07 | $921.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.38M 10-Q · filed 2023-11-07 | $1.84M derived: sum of 4 quarters · filed 2024-03-05 | ||
| 2022-06-30 | $469.00K 10-Q · filed 2023-08-08 | $928.00K 10-Q · filed 2023-08-08 | $1.39M derived: sum of 3 quarters · filed 2024-03-05 | $1.79M derived: sum of 4 quarters · filed 2024-03-05 | ||
| 2022-03-31 | $459.00K 10-Q · filed 2023-05-09 | $923.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.32M derived: sum of 3 quarters · filed 2024-03-05 | $2.99M derived: sum of 4 quarters · filed 2024-03-05 | ||
| 2021-12-31 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $859.00K derived: sum of 2 quarters · filed 2024-03-05 | $2.53M derived: sum of 3 quarters · filed 2024-03-05 | $3.31M 10-K · filed 2024-03-05 | ||
| 2021-09-30 | $395.00K 10-Q · filed 2022-11-08 | $2.07M derived: sum of 2 quarters · filed 2022-11-08 | $2.85M 10-Q · filed 2022-11-08 | $2.98M derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.46M 10-Q · filed 2022-08-05 | $2.59M derived: sum of 3 quarters · filed 2023-03-14 | $3.07M derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-03-31 | $783.00K 10-Q · filed 2022-05-05 | $917.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.40M derived: sum of 3 quarters · filed 2023-03-14 | $2.10M derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2020-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $618.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.32M derived: sum of 3 quarters · filed 2023-03-14 | $2.24M 10-K · filed 2023-03-14 | ||
| 2020-09-30 | $484.00K 10-Q · filed 2021-11-04 | $1.18M derived: sum of 2 quarters · filed 2021-11-04 | $2.11M 10-Q · filed 2021-11-04 | $4.04M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.62M 10-Q · filed 2021-08-05 | $3.56M derived: sum of 3 quarters · filed 2022-02-25 | $3.61M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $924.00K 10-Q · filed 2021-05-06 | $2.85M derived: sum of 2 quarters · filed 2022-02-25 | $2.91M derived: sum of 3 quarters · filed 2022-02-25 | $2.37M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2019-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.98M derived: sum of 2 quarters · filed 2022-02-25 | $1.44M derived: sum of 3 quarters · filed 2022-02-25 | $1.89M 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $51.00K 10-Q · filed 2019-11-06 | -$488.00K derived: sum of 2 quarters · filed 2020-08-07 | -$44.00K 10-Q · filed 2020-10-30 | $422.00K derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | -$539.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$95.00K 10-Q · filed 2020-08-07 | $371.00K derived: sum of 3 quarters · filed 2021-03-01 | $666.00K derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $444.00K 10-Q · filed 2020-05-06 | $910.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.21M derived: sum of 3 quarters · filed 2021-03-01 | $1.53M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $761.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.09M derived: sum of 3 quarters · filed 2021-03-01 | $1.34M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $295.00K 10-Q · filed 2019-11-06 | $621.00K derived: sum of 2 quarters · filed 2019-11-06 | $877.00K 10-Q · filed 2019-11-06 | $876.66K 10-Q · filed 2018-10-29 | $1.41M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $326.00K 10-Q · filed 2018-08-01 | $582.00K 10-Q · filed 2019-08-06 | $582.03K 10-Q · filed 2018-08-01 | $1.12M derived: sum of 3 quarters · filed 2020-02-24 | $1.44M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | $354.00K 10-Q · filed 2019-05-08 | $792.30K derived: sum of 2 quarters · filed 2020-02-24 | $1.11M derived: sum of 3 quarters · filed 2020-02-24 | $1.48M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | $438.30K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $757.30K derived: sum of 2 quarters · filed 2020-02-24 | $1.13M derived: sum of 3 quarters · filed 2020-02-24 | $1.44M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $319.00K 10-Q · filed 2018-10-29 | $689.00K derived: sum of 2 quarters · filed 2018-10-29 | $999.70K 10-Q · filed 2018-10-29 | |||
| 2017-06-30 | $370.00K 10-Q · filed 2018-08-01 | $680.85K 10-Q · filed 2018-08-01 | ||||
| 2016-12-31 | $788.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |